Condition
Tattoos
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed4
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT00580736Phase 1Completed
Optical Clearing of the Skin in Conjunction With Laser Treatments
NCT00540566Completed
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
NCT01754207Not ApplicableCompletedPrimary
Evaluation of the 755nm Alexandrite Laser for the Treatment of Tattoos
NCT02297321Not ApplicableCompletedPrimary
Evaluation of the Safety and Efficacy of the DeScribe™ Patch
NCT01811017Not ApplicableWithdrawnPrimary
Clinical Evaluation of 755nm Alexandrite Laser Versus Nanosecond 755nm Alexandrite
Showing all 5 trials